ADMA Biologics
ADMA
ADMA
188 hedge funds and large institutions have $613M invested in ADMA Biologics in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 88 increasing their positions, 46 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.64% more ownership
Funds ownership: 74.46% → 76.1% (+1.6%)
0% more capital invested
Capital invested by funds: $611M → $613M (+$1.96M)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
188
Holding in Top 10
5
Calls
$402K
Puts
$159K
Top Buyers
| 1 | +$7.61M | |
| 2 | +$5.91M | |
| 3 | +$5.27M | |
| 4 |
Millennium Management
New York
|
+$4.24M |
| 5 |
Goldman Sachs
New York
|
+$4.2M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$6.54M | |
| 3 | -$3.54M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.26M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$2.61M |